Acta Ophthalmol

1. JEPPESEN SK, Bek T
   Visual acuity is reduced with increasing central retinal thickness, but also with higher age and female sex in diabetic macular oedema.
   Acta Ophthalmol. 2026 Jun 23. doi: 10.1111/aos.70177.
   

   >> Share

   
   
2. FEDOTKINA O, Begum MC, Trinh XT, Ozgumus T, et al
   Genome-wide association and interaction analysis for proliferative retinopathy in adults with type 2 diabetes born during famine: The DOLCE study in Ukraine.
   Acta Ophthalmol. 2026 Jun 25. doi: 10.1111/aos.70187.
   

   >> Share

   
   

   
   Am J Hypertens

3. JIANG J
   Competing Risk of Death and the Hypertension-Atrial Fibrillation Association in Diabetes.
   Am J Hypertens. 2026 Jun 19:hpag063. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Manag Care

4. OUEINI R, Shirley B, Teigland C, Castora-Binkley M, et al
   Changes in persistence to basal insulin following the Medicare out-of-pocket cost cap.
   Am J Manag Care. 2026;32:e212-e216.
   

   >> Share

   
   
5. SPITERY A, Lobkovich A, Thomas E
   Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.
   Am J Manag Care. 2026;32:328-333.
   

   >> Share

   
   

   
   Am J Ophthalmol

6. ZHOU C, Shen Y, Li S, Li Y, et al
   Therapeutic response to anti-VEGF retreatment among eyes with stabilized vision after being lost to follow-up in diabetic macular edema: A nationwide, registry-based cohort study.
   Am J Ophthalmol. 2026 Jun 22:S0002-9394(26)00341.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

7. BAI B, Song Y, Tian L
   Exosome-like nanoparticles derived from Salvia miltiorrhiza promote diabetic wound healing by reducing oxidative stress and inflammation.
   Biochem Biophys Res Commun. 2026;829:154115.
   

   >> Share

   
   
8. KOOLABADI Z, Taghipour N, Rouhani M, Soleimani M, et al
   Formulation and characterization of 15d-PGJ2 loaded PLGA nanoparticles and in vitro evaluation of small intestinal submucosa integrated with nanoparticles for diabetic wound.
   Biochem Biophys Res Commun. 2026;829:153935.
   

   >> Share

   
   
9. WU Q, Hou D, Wang X, Fu Y, et al
   Allograft inflammatory factor-1 in macrophages promotes renal tubular cell epithelial-mesenchymal transition via the NF-kappaB/IL-1beta axis in diabetic kidney disease.
   Biochem Biophys Res Commun. 2026;829:154192.
   

   >> Share

   
   

   
   BMC Ophthalmol

10. MA JB, Qin MZ, Cao K, Zhang YP, et al
    Effects of blood pressure and blood glucose levels on foveal avascular zone area.
    BMC Ophthalmol. 2025;26:35.
    

    >> Share

    
    
11. WANG Y, Li J, Lin Y, Hu W, et al
    The association between magnesium and diabetic retinopathy: a cross-sectional study.
    BMC Ophthalmol. 2026 Jun 22. doi: 10.1186/s12886-026-05020.
    

    >> Share

    
    
12. YANG Q, Zhang H, Ke Y, Li X, et al
    Circumferential quantitative analysis of iris angiography reveals progressive pupillary-margin leakage across stages of diabetic retinopathy.
    BMC Ophthalmol. 2026 Jun 25. doi: 10.1186/s12886-026-05073.
    

    >> Share

    
    
13. DENG A, Gan Y, Da J, Ning Q, et al
    Early dynamic response on spectral-domain OCT predicts long-term visual outcome in diabetic macular edema treated with aflibercept.
    BMC Ophthalmol. 2026 Jun 25. doi: 10.1186/s12886-026-05030.
    

    >> Share

    
    
14. CHEN H, Shang Y, Yang P, Zhou Y, et al
    Association of early anti-VEGF Therapy anatomical response with renal function and OCT biomarkers in diabetic macular edema.
    BMC Ophthalmol. 2026 Jun 26. doi: 10.1186/s12886-026-05047.
    

    >> Share

    
    

    
    BMC Pediatr

15. GUAN Y, Xie J, Wang F, Ouyang Y, et al
    Application of gamified interventions in children with type 1 diabetes: a scoping review.
    BMC Pediatr. 2026 Jun 20. doi: 10.1186/s12887-026-07142.
    

    >> Share

    
    
16. RANAEI A, Lael-Monfared E, Peyman N
    The mediating role of self-care in the relationship between eHealth literacy and quality of life among adolescents with type 1 diabetes.
    BMC Pediatr. 2026 Jun 22. doi: 10.1186/s12887-026-07050.
    

    >> Share

    
    
17. FAWAZ L, Badawi N, Hasan M, Shamma R, et al
    Impact of telemonitoring on glycemic control and quality of life in pediatric patients with type 1 diabetes, single center interventional control study.
    BMC Pediatr. 2026;26:586.
    

    >> Share

    
    

    
    BMJ

18. WISE J
    Type 1 diabetes: Drug to delay onset approved for use in the NHS.
    BMJ. 2026;393:e100063.
    

    >> Share

    
    

    
    Clin Chem

19. CAO T, Fang M, Wallace AS, Daya Malek N, et al
    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.
    Clin Chem. 2026 Jun 25:hvag067. doi: 10.1093.
    

    >> Share

    
    

    
    Diabet Med

20. COCKCROFT EJ, Bright C, Nathan H, Farrow D, et al
    Barriers and enablers to physical activity in type 1 diabetes: A mixed-methods study of adults and parent-reported child perspectives in the UK.
    Diabet Med. 2026 Jun 19:e70378. doi: 10.1111/dme.70378.
    

    >> Share

    
    
21. RYGG MO, Moller AL, Curovic VR, Rasmussen DGK, et al
    Extracellular matrix proteins as risk markers for complications in type 1 diabetes.
    Diabet Med. 2026 Jun 20:e70396. doi: 10.1111/dme.70396.
    

    >> Share

    
    
22. GAVOYANNIS G, Turner J, Fox S, Mani H, et al
    Early-onset type 2 diabetes (EOT2D): A clinical review of classification leading to 10% reclassification.
    Diabet Med. 2026 Jun 25:e70409. doi: 10.1111/dme.70409.
    

    >> Share

    
    
23. QIAN T, Guo D, Zhang M, Liu Y, et al
    Beyond HbA1c: A CGM-centred three-pillar framework for glycaemic variability in pre-diabetes and type 2 diabetes.
    Diabet Med. 2026 Jun 25:e70404. doi: 10.1111/dme.70404.
    

    >> Share

    
    
24. SUSHKO K, Sherifali D, Smith K, L Lipscombe L, et al
    Exploring women's preferences for diabetes prevention programs after gestational diabetes: A qualitative descriptive study.
    Diabet Med. 2026 Jun 25:e70397. doi: 10.1111/dme.70397.
    

    >> Share

    
    
25. GOLDING JA, Long SO, Hope SV, Wright JE, et al
    The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational study.
    Diabet Med. 2026 Jun 23:e70406. doi: 10.1111/dme.70406.
    

    >> Share

    
    
26. SYLEOUNI ME, Lee TTM, Carrieri F, Scott EM, et al
    HbA1c improvement in pregnant women with type 1 diabetes using the CamAPS FX automated insulin delivery (AID) system: Clinical and economic outcomes.
    Diabet Med. 2026 Jun 21:e70394. doi: 10.1111/dme.70394.
    

    >> Share

    
    
27. L'AMIE A, Vincent AL, Jefferies CA, Braatvedt G, et al
    Wolfram syndrome and diabetes mellitus in Aotearoa, New Zealand: Phenotype and response to GLP-1 receptor agonist therapy.
    Diabet Med. 2026 Jun 21:e70405. doi: 10.1111/dme.70405.
    

    >> Share

    
    

    
    Diabetes

28. SAKAKI K, Murakami T, Yabe D, Inagaki N, et al
    Response to Comment on Sakaki et al. Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
    Diabetes. 2026;75:e23-e24.
    

    >> Share

    
    
29. PAGE B
    Diabetes Spotlight: Rana Gupta, PhD-Developmental Biology and Adipose Tissue.
    Diabetes. 2026;75:1051.
    

    >> Share

    
    
30. VAZQUEZ ARREOLA E, Knowler WC, Hanson RL
    Global and Partitioned Polygenic Risk Scores: Associations With Pathophysiology and Incidence of Type 2 Diabetes in People With Prediabetes.
    Diabetes. 2026;75:1329-1337.
    

    >> Share

    
    
31. DARDARI D
    Glycemic Improvement and Active Charcot Neuroarthropathy: Osteocalcin as a Candidate Biomarker of Transient Skeletal Vulnerability.
    Diabetes. 2026;75:1067-1070.
    

    >> Share

    
    
32. SAINT-MARTIN C, ElSheikh A, Jacqueminet S, Arnoux JB, et al
    Co-occurrence of Loss-of-Function GCK and ABCC8 Variants in a Pedigree With a Spectrum of Dysglycemia.
    Diabetes. 2026;75:1323-1328.
    

    >> Share

    
    
33. LI S, Wang J, Xin C, Dong Y, et al
    beta-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.
    Diabetes. 2026;75:1125-1141.
    

    >> Share

    
    
34. HOU Y, Chen T, Zhou J, Guo Z, et al
    The Mechanism of TNF-alpha Combined With High Glucose in Regulating Calnexin Aggravates Endoplasmic Reticulum Stress in Endothelial Cell Injury of Diabetic Retinopathy.
    Diabetes. 2026;75:1150-1161.
    

    >> Share

    
    

    
    Diabetes Care

35. MAAGENSEN H, Hoyerup SO, Jensen JS, Thuesen ACB, et al
    Empagliflozin in HNF1A-MODY (MODY3): A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Diabetes Care. 2026;49:1166-1174.
    

    >> Share

    
    
36. ESPELAND MA, Semelka CT, Kritchevsky SB, Evans JK, et al
    The Look AHEAD Research Program: A 25-Year Retrospective From the Perspective of Geroscience.
    Diabetes Care. 2026;49:1159-1162.
    

    >> Share

    
    
37. HANDELSMAN Y, Fonseca V, Buse JB, Auchus RJ, et al
    Comment on Nieman and Muniyappa Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?
    Diabetes Care. 2026;49:e131-e132.
    

    >> Share

    
    
38. LI B, Han D
    Comment on Bragg et al. Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization Study.
    Diabetes Care. 2026;49:e134-e135.
    

    >> Share

    
    
39. LAMOTHE S, Bourcigaux N, Vatier C, Christin-Maitre S, et al
    Comment on Korakas et al. 780G Hybrid Closed-Loop Pump as Adjunct to Metreleptin in Lipodystrophy-Associated Diabetes: Three Case Observations.
    Diabetes Care. 2026;49:e136-e137.
    

    >> Share

    
    
40. ROONEY MR, Echouffo Tcheugui JB, Chen J, Walker KA, et al
    Proteomic Signatures of 3-Year Progression From Impaired Fasting Glucose to Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetes Care. 2026 Jun 25:dc260498. doi: 10.2337/dc26-0498.
    

    >> Share

    
    
41. QIAN J, Stefanovski D, Andersen PAK, Vujovic N, et al
    Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant.
    Diabetes Care. 2026 Jun 25:dc260164. doi: 10.2337/dc26-0164.
    

    >> Share

    
    
42. GALINDO RJ, Moazzami B, Gerges A, Flores I, et al
    Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.
    Diabetes Care. 2026 Jun 26:dc260404. doi: 10.2337/dc26-0404.
    

    >> Share

    
    
43. AHMED M, Kubota-Mishra E, Siller AF, Davis A, et al
    A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.
    Diabetes Care. 2026 Jun 26:dc260464. doi: 10.2337/dc26-0464.
    

    >> Share

    
    
44. HENNEKES MHCL, Haugvik S, Wit M, Toschi E, et al
    Erratum. Diabetes Body Project: Acute Effects of an Eating Disorder Prevention Program for Young Women With Type 1 Diabetes. A Multinational Randomized Controlled Trial. Diabetes Care 2025;48:220-225.
    Diabetes Care. 2026 Jun 23:dc26er09a. doi: 10.2337.
    

    >> Share

    
    
45. LESLIE RD, Zhou Z, Pozzilli P
    Characteristic Traits of Type 1 Diabetes by Age at Presentation Go Over the Rainbow.
    Diabetes Care. 2026;49:1163-1165.
    

    >> Share

    
    
46. YANG W, Li M
    Comment on Yu et al. Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes.
    Diabetes Care. 2026;49:e133.
    

    >> Share

    
    
47. CAO YT, Zhou XQ
    Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
    Diabetes Care. 2026;49:e127-e128.
    

    >> Share

    
    
48. HUTTASCH M, Roden M
    Response to Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
    Diabetes Care. 2026;49:e129-e130.
    

    >> Share

    
    

    
    Diabetes Obes Metab

49. ABDULSALAM R, Jebb SA, Michalopoulou M, Piernas C, et al
    Postpartum Body Weight and Cardiometabolic Biomarker Trajectories in Women With Gestational Diabetes: A Population-Based Matched Cohort Study.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.70994.
    

    >> Share

    
    
50. XIAO Q, Zheng Y, Zhao H, Li Y, et al
    Large-Scale Proteomics Uncovers Pre-Disease Inflammation-Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.71038.
    

    >> Share

    
    
51. ARTEAGA-DIAZ JM, Torres-Grajales JL, Sauque-Reyna L, Salamanca-Carrillo C, et al
    Real-World Effectiveness and Safety of iGlarLixi in People With Type 2 Diabetes in LATAM Region: A Subanalysis of the SUCCESS Study.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.71018.
    

    >> Share

    
    
52. EKINCI EI, Maldonado SG, Unseld A, Martinez JA, et al
    Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.70861.
    

    >> Share

    
    
53. MAIER GA, Hofmann RA, Roden M, Rathmann W, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Diabetes Obes Metab. 2026 Jun 22. doi: 10.1111/dom.71023.
    

    >> Share

    
    
54. WHARTON S, Stefanski A, Chen J, Rao G, et al
    Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials.
    Diabetes Obes Metab. 2026 Jun 23. doi: 10.1111/dom.71032.
    

    >> Share

    
    
55. LIN YK, Soholm U, Ratzki-Leewing A, Ye W, et al
    The Impact of Hypoglycaemia on Quality of Life in Adults With Type 1 Diabetes Using Contemporary Diabetes Technologies: A US National Survey.
    Diabetes Obes Metab. 2026 Jun 25. doi: 10.1111/dom.71028.
    

    >> Share

    
    
56. LI X, Ye X, Tang J, Wang Q, et al
    Glycaemic Control During School Days and Holidays in Children and Adolescents With Type 1 Diabetes Using Open-Source Android Artificial Pancreas Systems: A Real-World Study.
    Diabetes Obes Metab. 2026 Jun 25. doi: 10.1111/dom.70970.
    

    >> Share

    
    
57. PARK S, Jung J, Jeong J, Jang MH, et al
    Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.
    Diabetes Obes Metab. 2026 Jun 25. doi: 10.1111/dom.71042.
    

    >> Share

    
    

    
    Diabetologia

58. MCCARTHY A, Kent G, Thomas J, Martine-Edith G, et al
    Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study.
    Diabetologia. 2026 Jun 20. doi: 10.1007/s00125-026-06775.
    

    >> Share

    
    
59. MOHAN V
    Impacting lives of people with diabetes: lessons learnt in India may be applicable to other low- and middle-income countries.
    Diabetologia. 2026 Jun 23. doi: 10.1007/s00125-026-06776.
    

    >> Share

    
    
60. MATEJKO B, Cyranka K, Sudul P, Susul K, et al
    Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults >/=65 years with type 1 diabetes: a randomised, single-centre study.
    Diabetologia. 2026 Jun 25. doi: 10.1007/s00125-026-06780.
    

    >> Share

    
    
61. YILMAZ UC, Kizilay DO, Kurt OK, Balaban Berber IB, et al
    Autoantibody screening in children who are first-degree relatives of individuals with type 1 diabetes in a sibling-dominant cohort in Turkey: a multicentre study on prevalence, determinants and post-screening parent-child anxiety.
    Diabetologia. 2026 Jun 25. doi: 10.1007/s00125-026-06783.
    

    >> Share

    
    
62. MADDALONI E, Pezzica S, Amendolara R, Sabatini S, et al
    Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.
    Diabetologia. 2026 Jun 26. doi: 10.1007/s00125-026-06777.
    

    >> Share

    
    
63. SAID N, Jones I, Anderson-Baucum EK, Evans-Molina C, et al
    SARS-CoV-2 and diabetes: a post-pandemic reappraisal.
    Diabetologia. 2026 Jun 27. doi: 10.1007/s00125-026-06785.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

64. GUO Z, Li X, Chen X, Ma X, et al
    Senp1 O-GlcNAcylation Promotes Mitochondrial Fragmentation by Regulating Fis1 SUMO1-ylation Underlying Diabetic Cataract.
    Invest Ophthalmol Vis Sci. 2026;67:44.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

65. COHEN A, Karmi O, Abdulhag UN, Klopstock T, et al
    Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.
    J Clin Endocrinol Metab. 2026 Jun 24:dgag250. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

66. MAYYAS F
    Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.
    J Diabetes Complications. 2026;40:109362.
    

    >> Share

    
    

    
    J Hypertens

67. SETJIADI D, Delles C, Kroon AA, Ressink K, et al
    Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study.
    J Hypertens. 2026 Feb 16. doi: 10.1097/HJH.0000000000004265.
    

    >> Share

    
    

    
    J Nutr

68. FRANKENFELD CL, Movva N, Hooda N, Gauthier J, et al
    Analysis of National Health and Nutrition Examination Survey (NHANES): Nutrient, food, and beverage intake of GLP1-RA users with Type 2 Diabetes, 2007-2020.
    J Nutr. 2026 Jun 22:101685. doi: 10.1016/j.tjnut.2026.101685.
    

    >> Share

    
    

    
    Lancet

69. KHUNTI K, Zaccardi F, Mehta R, Gregg EW, et al
    Epidemiology of cardiometabolic multiple long-term conditions.
    Lancet. 2026;407:2641-2654.
    

    >> Share

    
    

    
    Ophthalmol Retina

70. MUAYAD J, Butt FR, Loya A, Chauhan MZ, et al
    Systemic Anemia and the Risk of Diabetic Macular Edema and Anti-VEGF Injections.
    Ophthalmol Retina. 2026 Jun 26:S2468-6530(26)00314.
    

    >> Share

    
    

    
    PLoS Med

71. CHAN L, Xu W, Chan EWY, Wan EYF, et al
    Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.
    PLoS Med. 2026;23:e1005136.
    

    >> Share

    
    

    
    PLoS One

72. HUANG L, Wang TM, Sugimoto JD, Heberer KR, et al
    Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort.
    PLoS One. 2026;21:e0351992.
    

    >> Share

    
    
73. BHASIN G, Dafale RS, Kamath SU, Prabhu MM, et al
    Comparative performance of invasive, semi-invasive, and non-invasive insulin resistance-related indices across prediabetes and normoglycemia.
    PLoS One. 2026;21:e0351950.
    

    >> Share

    
    
74. PROBANDARI A, Modesty K, Tjung V, Sitepu BE, et al
    Potentials, barriers, and strategies for integrating tuberculosis, diabetes mellitus, and hypertension case management: A scoping review.
    PLoS One. 2026;21:e0345708.
    

    >> Share

    
    
75. RAVINDRARAJAH R, Gittins M, Paterson L, Rogers G, et al
    Clinical and cost-effectiveness of the digital intervention, MyWay Diabetes, in people with type 2 diabetes living in Greater Manchester during the COVID-19 pandemic.
    PLoS One. 2026;21:e0349232.
    

    >> Share

    
    
76. LIU M, Song H, Zhang C, Li J, et al
    Bioinformatics analysis of pyroptosis-related differentially expressed genes in sepsis and diabetes mellitus.
    PLoS One. 2026;21:e0352310.
    

    >> Share

    
    
77. OH S, Kim S, Yun J, Min JK, et al
    Family history of diabetes and glycemic progression: A propensity score-based analysis using health checkup data.
    PLoS One. 2026;21:e0352348.
    

    >> Share

    
    
78. LI Y, Zou Z, Yi S, Yang Y, et al
    An intervention study of the general practice management of older adults with cardiovascular metabolic comorbidities.
    PLoS One. 2026;21:e0350895.
    

    >> Share

    
    
79. RAMPAL S, Lopes CA, Hadi P, Neela VK, et al
    Risk factors associated with diabetic foot amputation: A retrospective study from a tertiary hospital in Central Malaysia.
    PLoS One. 2026;21:e0335328.
    

    >> Share

    
    
80. CHHAM S, Ir P, Olmen JV, Buffel V, et al
    Exploring the potential of community health workers in type-2 diabetes and hypertension management in Cambodia.
    PLoS One. 2026;21:e0351958.
    

    >> Share

    
    

    
    Retina

81. LI B, Li S, Cun Y
    THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.
    Retina. 2026 Apr 28. doi: 10.1097/IAE.0000000000004869.
    

    >> Share

    
    
82. TORRES-VILLAROS H, Lachiver L, Fajnkuchen F, Morel JB, et al
    Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.
    Retina. 2026 Jun 23. doi: 10.1097/IAE.0000000000004912.
    

    >> Share

    
    

    
    Stroke

83. LU L, Yang B, Wang Y, Zhu C, et al
    Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial.
    Stroke. 2026 May 18. doi: 10.1161/STROKEAHA.125.056010.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share